Hims & Hers (HIMS) CCO reports planned sale under 10b5-1; 13,749 shares disposed

Q: Who filed the Form 4 for HIMS and what is their role?

The filing reports Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc.

Q: What transaction is reported on the Form 4 for HIMS?

On 09/17/2025 Michael Chi sold 13,749 shares of Class A common stock at $50.50 per share.

Q: How many HIMS shares does Michael Chi own after the reported transaction?

The Form 4 reports 297,139 shares beneficially owned following the sale.

Q: Who signed the Form 4 and when was it signed?

The form is signed by Kimberly Mather, Attorney-in-Fact for Michael Chi on 09/19/2025 .

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc. (HIMS), reported an insider sale. On 09/17/2025 he disposed of 13,749 shares of Class A common stock at $50.50 per share, leaving him with 297,139 shares beneficially owned after the transaction. The Form 4 states the sales were executed under a Rule 10b5-1 trading plan adopted by Mr. Chi on March 4, 2025. The filing is signed by Kimberly Mather as attorney-in-fact for Michael Chi on 09/19/2025. The document contains no additional financial results or commentary.

Positive

Sale executed under a Rule 10b5-1 trading plan, indicating pre-planned compliance with insider trading rules

Negative

Insider disposal of 13,749 shares which reduced the reporting person's holdings to 297,139 shares

Insights

TL;DR: A pre-established 10b5-1 plan governed the sale, indicating compliance and reduced signaling of opportunistic timing.

The filing shows an insider sale executed under a Rule 10b5-1 plan adopted on March 4, 2025, which formalizes trading windows and reduces concerns about trading on material nonpublic information. The amount sold—13,749 shares—represents a portion of the reporting person’s holdings, leaving 297,139 shares. From a governance perspective, the presence of a plan and an attorney-in-fact signature suggests procedural adherence; the filing does not disclose any other governance actions or related-party transactions.

TL;DR: Insider reduced holdings via a planned sale; transaction is informative but not necessarily material to valuation alone.

The reported sale at $50.50 per share on 09/17/2025 reduced the reporting person’s stake by 13,749 shares. The Form 4 provides clear trade details and indicates execution under a documented 10b5-1 plan, which limits interpretive value about the company’s near-term outlook. No other transactions, derivative positions, or explanatory financial data are included, so direct impact on HIMS valuation cannot be assessed from this filing alone.

Insider Trade Summary

Net Seller: 13,749 shares ($694,325)

Net Sell 1 txn

Insider Chi Michael

Role Chief Commercial Officer

Sold 13,749 shs ($694K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	13,749	$50.50	$694K

Holdings After Transaction: Class A Common Stock — 297,139 shares (Direct)

Footnotes (1)

[object Object]

Form 4 Insider Transactions: What Each Field Means →

09/19/2025 - 04:27 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Chi Michael

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

94123

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	09/17/2025		S⁽¹⁾		13,749	D	$50.5	297,139	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Michael Chi	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

Who filed the Form 4 for HIMS and what is their role?

The filing reports Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc.

What transaction is reported on the Form 4 for HIMS?

On 09/17/2025 Michael Chi sold 13,749 shares of Class A common stock at $50.50 per share.

How many HIMS shares does Michael Chi own after the reported transaction?

The Form 4 reports 297,139 shares beneficially owned following the sale.

Was the sale part of an established plan?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025.

Who signed the Form 4 and when was it signed?

The form is signed by Kimberly Mather, Attorney-in-Fact for Michael Chi on 09/19/2025.